Use of ceftriaxone as an alternative treatment method in pregnant women diagnosed with syphilis – a single centre experience

Author:

Hartmane Ilona12ORCID,Ivdra Iveta12,Mikazans Ingmars12,Princevs Aleksejs1,Teterina Irena3ORCID,Bondare-Ansberga Vanda12ORCID,Reinberga Lelde12

Affiliation:

1. Clinic for Dermatology and Sexually Transmitted Diseases, Riga 1st Hospital, Rīga, Latvia

2. Department of Dermatology and Venereology, Faculty of Medicine, Rīga Stradiņš University, Rīga, Latvia

3. Department of Pharmacology, Rīga Stradiņš University, Rīga, Latvia

Abstract

Background There are few data on the use of ceftriaxone in pregnant women diagnosed with syphilis. The aim of this study was to investigate the safety and efficacy of ceftriaxone as an alternative treatment option for syphilis during pregnancy. Methods A retrospective analysis of 79 pregnant women diagnosed with syphilis and treated with ceftriaxone was conducted. Results No cases of intolerance, Jarisch-Herxheimer reactions, or allergic reactions were recorded. The average time to seronegativation for secondary syphilis with symptoms was 6.14 months ± 2.76, and for latent forms, it was 7.52 months ± 1.84. Patients received no additional treatment. No serious adverse drug reactions were reported. Conclusions Data from our study support the use of ceftriaxone as an effective and safe alternative treatment for pregnant women diagnosed with syphilis when penicillin therapy is contraindicated or unavailable.

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Public Health, Environmental and Occupational Health,Dermatology

Reference30 articles.

1. Statistics on sexually transmitted infections. SPKC (CDCP). Available from: https://www.spkc.gov.lv/lv/seksuali-transmisivo-infekciju-statistika

2. Amoxicillin and Ceftriaxone as Treatment Alternatives to Penicillin for Maternal Syphilis

3. Jaunākā informācija no Eiropas Zāļu aģentūras par antibiotiku piegādes pārtraukumiem ES | Zāļu valsts aģentūra. Available from: https://www.zva.gov.lv/lv/jaunumi-un-publikacijas/jaunumi/jaunaka-informacija-no-eiropas-zalu-agenturas-par-antibiotiku-piegades-partraukumiem-es

4. List of diagnoses and generic names of reimburesed drugs/medical devices 2023. Available from: https://www.vmnvd.gov.lv/lv/media/22197/download?attachment

5. A Study Evaluating Ceftriaxone as a Treatment Agent for Primary and Secondary Syphilis in Pregnancy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3